CCTA Resources

Society-Based Guidelines

SCCT Guidelines for the Performance and Acquisition of Coronary Computed Tomographic Angiography (2016)

RCR Guidelines 2014 (UK): Standards of Practice of Computed Tomography Coronary Angiography (CTCA) in Adult Patients

Videos: CCTA Acquisition Best Practices

How to Perform Optimal Coronary CT Angiography

Webinar: A 6 segment video by Dr. Guy Weigold sharing best practices for the acquisition of CCTA, image reconstruction, reducing artifacts, post processing techniques and interpretation of the results that lead to accurate clinical interpretation. The webinar also discusses cases that include FFRCT results and the impact of FFRCT in clinical decision making.

Instructions: In order to watch this free webinar, please create a guest account on the SCCT website. Upon completing registration, please click on SCCT Learning Center under the Education tab. The webinar will be available in your Education Library.

Impact of Nitrates in the Acquisition of Coronary CT Angiography

A 4 segment video by Dr. Jonathon Leipsic MD, FRCPC, FSCCT summarizing the rationale and best practices for administering nitroglycerin for acquiring CCTA in accordance with the SCCT guidelines. The video also highlights the effect of nitrates administration on the coronary vasculature, and ultimately the CCTA diagnostic accuracy.


Section 1: Effect on Vasculature

Section 2: Nitrate Recommendations

Section 3: Physiologic effects, Dosage and Timing

Section 4: Summary

Implementation Recommendations


  1. The ability to meet minimum quality requirements for the HeartFlow Analysis process (minimum 8/10 consecutive cases pass initial quality acceptance).
  2. Willingness to participate in the HeartFlow onboarding process which includes on-site review of the institution’s CCTA program, training for imagers on HeartFlow requirements, review of CCTA best practices and SCCT guidelines for performance of CCTA.
  3. At least one accredited CCTA reader (or equivalent experience of >150 cardiac CTs) – may be SCCT Level 1+ or accredited through other organizations/fellowship.
  4. Access to scheduled time on the scanner for CCTA.


  1. Nurses available and experienced with administering IV beta blockers and monitoring patients for cardiac scans.
  2. An SCCT level 2 accredited cardiac reader.
  3. A dedicated patient preparation area for the CCTA program.

Customizable Resources

All of these resources are available to HeartFlow sites and can be customized. Please reach out to a local HeartFlow CT Application Specialist to gain access.

CCTA Technologist Training

The training provides 2.25 Category A ASRT credit hours. It reviews the current invasive and noninvasive technologies used to assess the coronary artery disease (CAD). The discussions also focus on how the growth of coronary CT angiography (CCTA) are answering patient and clinician questions more effectively than ever before.

Please contact your local HeartFlow Account Manager to schedule and customize a training.

Heart Rate Control Guidelines for Performance of CCTA

Provides guidelines on administering Beta blockers to improve CCTA acquisition. This poster can be created with site specific guidelines.

Coronary CTA Acquisition Protocols

Provides instructions and important reminders on CCTA acquisition protocols such as patient preparation, image acquisition, and image reconstruction. This poster can be created with site specific protocols and is intended to be displayed at the CT scanner console.

Presentation: Evidence on CCTA

Reviews evidence on the diagnostic accuracy of CCTA, and the impact of CCTA on patient management and outcomes. CT readers and referring physicians can utilize this tool in their pre-authorization peer to peer discussions with the medical directors of various health plans.

HeartFlow CT Applications Support

HeartFlow’s field-based Clinical Account and CT Applications Teams help advance the site’s CT capabilities throughout the lifetime of their account. These teams use best practices and several education and teaching methods (including hands-on case reviews and training).

Site Startup

HeartFlow’s implementation team, including CT Applications specialists and Clinical Account Managers, actively work with sites to ensure they can achieve acceptable image quality for HeartFlow Analysis. HeartFlow performs a baseline evaluation of CCTA quality and provides detailed image quality feedback and observations of site’s practices (note: this baseline review is conducted following HeartFlow’s on-site assessment and review training on best practices for CCTA and a review of the SCCT guidelines). Training and educational materials are provided to imaging physicians and radiographers on SCCT cardiac CTA guidance and image specifications for the HeartFlow Analysis. In addition, training on the use of the HeartFlow Analysis is provided to radiologists, radiographers and cardiologists, as well as other support staff.

Continuous Monitoring

HeartFlow’s CT Applications team works with customers to ensure imaging quality continues to be sufficient for HeartFlow Analysis. HeartFlow monitors quality and acquisition parameters, and routinely reviews cases and best practices with sites to optimize acceptance rates for HeartFlow Analysis.

Education Programs

In addition to site-specific education, HeartFlow sponsors educational events at large conferences, symposia, etc., and supports physician continuing education. HeartFlow offers education programs for Radiographers and Clinicians alike, including physician-led videos, webinars, peer-to-peer discussions, and instructor-led programs (including some with SOR or category A ASRT Credits).

Contact Us

*Required fields

Request the HeartFlow Analysis Near You

If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.

*Required fields

残念ながら、GDPR 規制により、この Web フォームを通じて求人への応募やキャリアに関する問い合わせを受け付けることはできません。弊社を通じてお申込みください 採用ページ. ご関心をお寄せいただきありがとうございます!


HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用​​することを目的としています。


さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.

The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.

For additional indication information about the HeartFlow Analysis, please visit

If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.

Please apply for research grants through our online submission form.

Unfortunately, we cannot take job applications or career inquiries through this web form due to GDPR regulations. Please apply through our Careers Page. Thank you for your interest!

Campbell Rogers, M.D., F.A.C.C.

Executive Vice President and Chief Medical Officer

Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.

He received his A.B. from Harvard College and his M.D. from Harvard Medical School.